BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:18 PM
 | 
Jul 10, 2007
 |  BC Extra  |  Company News

Genentech, Tercica partner to combine Nutropin, Increlex

DNA and TRCA partnered to develop and commercialize two products: one to treat short stature and the other for adult growth hormone deficiency (AGHD). The products will be combinations of DNA's Nutropin AQ somatropin, a liquid formulation of recombinant human growth hormone (hGH), and TRCA's Increlex mecasermin recombinant human insulin-like...

Read the full 239 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >